Ghent University Academic Bibliography

Advanced

Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid

SANDRINE ASPESLAGH, Yali Li, Tine Decruy UGent, Katrien Van Beneden UGent, Koen Venken UGent, Matthias Trappeniers UGent, Serge Van Calenbergh UGent, Dirk Zajonc and Dirk Elewaut UGent (2010) CLINICAL IMMUNOLOGY. 135(suppl.). p.S40-S40
Please use this url to cite or link to this publication:
author
organization
year
type
conference (meetingAbstract)
publication status
published
subject
in
CLINICAL IMMUNOLOGY
Clin. Immunol.
volume
135
issue
suppl.
article number
abstract T.6
pages
S40 - S40
conference name
10th Annual meeting of the Federation of Clinical Immunology Societies (FOCIS 2010)
conference location
Boston, MA, USA
conference start
2010-06-24
conference end
2010-06-27
Web of Science type
Meeting Abstract
Web of Science id
000277953700105
JCR category
IMMUNOLOGY
JCR impact factor
3.932 (2010)
JCR rank
36/133 (2010)
JCR quartile
2 (2010)
ISSN
1521-6616
DOI
10.1016/j.clim.2010.03.121
language
English
UGent publication?
yes
classification
C3
copyright statement
I have transferred the copyright for this publication to the publisher
id
1234121
handle
http://hdl.handle.net/1854/LU-1234121
date created
2011-05-24 15:02:30
date last changed
2016-12-21 15:40:41
@inproceedings{1234121,
  articleno    = {abstract T.6},
  author       = {ASPESLAGH, SANDRINE and Li, Yali and Decruy, Tine and Van Beneden, Katrien and Venken, Koen and Trappeniers, Matthias and Van Calenbergh, Serge and Zajonc, Dirk and Elewaut, Dirk},
  booktitle    = {CLINICAL IMMUNOLOGY},
  issn         = {1521-6616},
  language     = {eng},
  location     = {Boston, MA, USA},
  number       = {suppl.},
  pages        = {abstract T.6:S40--abstract T.6:S40},
  title        = {Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid},
  url          = {http://dx.doi.org/10.1016/j.clim.2010.03.121},
  volume       = {135},
  year         = {2010},
}

Chicago
ASPESLAGH, SANDRINE, Yali Li, Tine Decruy, Katrien Van Beneden, Koen Venken, Matthias Trappeniers, Serge Van Calenbergh, Dirk Zajonc, and Dirk Elewaut. 2010. “Optimizing the iNKT Cell Dependent Antitumor Effect Using an Altered Glycolipid.” In Clinical Immunology, 135:S40–S40.
APA
ASPESLAGH, S., Li, Y., Decruy, T., Van Beneden, K., Venken, K., Trappeniers, M., Van Calenbergh, S., et al. (2010). Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid. CLINICAL IMMUNOLOGY (Vol. 135, pp. S40–S40). Presented at the 10th Annual meeting of the Federation of Clinical Immunology Societies (FOCIS 2010).
Vancouver
1.
ASPESLAGH S, Li Y, Decruy T, Van Beneden K, Venken K, Trappeniers M, et al. Optimizing the iNKT cell dependent antitumor effect using an altered glycolipid. CLINICAL IMMUNOLOGY. 2010. p. S40–S40.
MLA
ASPESLAGH, SANDRINE, Yali Li, Tine Decruy, et al. “Optimizing the iNKT Cell Dependent Antitumor Effect Using an Altered Glycolipid.” Clinical Immunology. Vol. 135. 2010. S40–S40. Print.